Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2025 ,inter alia, to consider and approve the financial results of the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vanta Bioscience Ltd has informed BSE that its Board of Directors meeting, originally scheduled for July 24, 2025, has been postponed to July 29, 2025 at 6:00 PM. The meeting is being held to consider and approve the financial results for the period ended March 31, 2025. The postponement has been attributed to unforeseen and unavoidable circumstances. The trading window for designated persons remains closed from April 1, 2025 till July 31, 2025 in line with insider trading norms.
This is an administrative update with no direct impact on shareholders. The short postponement is procedural, but the actual financial results will be the key driver of stock reaction once announced on or after July 29, 2025.